Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
Autor: | Tomohiko Akahoshi MD, PhD, Noriyuki Kaku MD, PhD, Yuji Shono MD, PhD, Yuzo Yamamoto MD, PhD, Keita Takahashi MD, PhD, Takeshi Iyonaga MD, PhD, Kenta Momii MD, Masaaki Nishihara MD, PhD, Jun Maki MD, PhD, Kentaro Tokuda MD, PhD, Ken Yamaura MD, PhD |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022) |
Druh dokumentu: | article |
ISSN: | 1938-2723 10760296 |
DOI: | 10.1177/10760296221135790 |
Popis: | Recombinant antithrombin gamma (rAT) is reported as an effective drug for patients with disseminated intravascular coagulation (DIC) in Japan. As the appropriate dose and targeted AT activity remain unknown, this study aimed to determine these aspects for sepsis-induced DIC. Thirty-one patients with septic shock and DIC with AT levels |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |